There are currently 1290 clinical trials in Miami, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Miami, GSK Investigational Site, University of Miami Miller School of Medicine-Sylvester Cancer Center and University of Miami Miller School of Medicine. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
A Phase 2 Study of RTA 901 in Patients With Diabetic Peripheral Neuropathic Pain (CYPRESS)
NCT05895552
Recruiting
This is a 2-part, randomized, placebo-controlled, double-blind, Phase 2 study to evaluate the safety, tolerability, efficacy, and PK of RTA 901 in qualified subjects with DPNP. Each study part will be randomized into 3 treatment arms; 2 different doses of RTA 901 and a Placebo. The doses of RTA 901 in Part 2 will be selected based on the Exposure-Response (E-R) analyses of data from Part 1. A total of 384 subjects will be randomized in this study. Each part will have 192 subjects, with 64 subjec... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/31/2024
Locations: Finlay Medical Research, Miami, Florida
Conditions: Diabetic Peripheral Neuropathic Pain
Register for Updates
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
NCT02997709
Recruiting
The purpose of this research study is to learn about: 1) How standard radiation treatment to prostate (primary radiotherapy) or the pelvis after prostatectomy (postoperative radiotherapy) may cause changes in MRI and PET imaging traits that might be used in the future to predict response. 2) Comparison of such MRI and PET imaging traits with the number of circulating tumor cells (CTCs) present in the blood prior to treatment and the changes in these counts after treatment. 3) How MRI and PET ima... Read More
Gender:
Male
Ages:
30 years and above
Trial Updated:
01/30/2024
Locations: University of Miami, Miami, Florida
Conditions: Prostate Cancer
Register for Updates
Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)
NCT05593614
Recruiting
The purpose of this clinical trial is to compare the efficacy of twice daily applications of ATX01 (10% & 15%) versus placebo during a 12-week treatment period in treating chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivor patients.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/30/2024
Locations: MGM Medical Care Research & Rehab, LLC, Miami, Florida
Conditions: Chemotherapy-induced Peripheral Neuropathy
Register for Updates
Exposure Therapy Consortium (ETC) for Anxiety Sensitivity
NCT05225740
Recruiting
The current study seeks to test differences between a single-session large-group format of standard exposure, enhanced exposure, and a control condition in treating anxiety sensitivity. It is hypothesized that 1) participants assigned to either exposure condition will evidence greater reductions in anxiety sensitivity from pre-treatment to posttreatment relative to those in the control condition; 2) participants assigned to the enhanced exposure condition will evidence greater reductions in anxi... Read More
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
01/30/2024
Locations: The University of Miami, Miami, Florida
Conditions: Elevated Anxiety Sensitivity
Register for Updates
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
NCT01999361
Recruiting
This is a single-center, prospective, open label study in islet transplant recipients after complete islet graft rejection/loss, defined as stimulated c-peptide ≤0.3 ng/mL.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
01/29/2024
Locations: Diabetes Research Institute, Miami, Florida
Conditions: Type 1 Diabetes Mellitus
Register for Updates
Long Term Follow up of Recipients of Functional Islet Allografts
NCT01999374
Recruiting
Since its inception, the Diabetes Research Institute (DRI) has made significant contributions to the field of diabetes, pioneering many of the techniques used in diabetes centers around the world. Through several clinical trials, DRI has demonstrated that diabetes can be successfully reversed as a result of islet cell transplant. Over the years the following protocols in islet cell transplantation have been initiated: 2000/0329; 2000/0196; 2004/0205; 2000/024; 2006/0200; 2006/0508; 2006/0210.... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
01/29/2024
Locations: Diabetes Research Institute, Miami, Florida
Conditions: Type 1 Diabetes Mellitus
Register for Updates
Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
NCT02000687
Recruiting
This is a single-center, prospective, open label study in islet transplant recipients following islet graft loss.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
01/29/2024
Locations: Diabetes Research Institute, Miami, Florida
Conditions: Type 1 Diabetes Mellitus
Register for Updates
Fecal Microbiota Transplant National Registry
NCT03325855
Recruiting
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
Gender:
All
Ages:
All
Trial Updated:
01/29/2024
Locations: University of Miami, Miller School of Medicine, Miami, Florida
Conditions: Fecal Microbiota Transplantation, Clostridium Difficile Infection, Gut Microbiome
Register for Updates
Tele-Harm Reduction
NCT05208697
Recruiting
The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/29/2024
Locations: University of Miami, Miami, Florida
Conditions: IV Drug Usage, HIV Infections, Hepatitis C
Register for Updates
TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis Reset
NCT04254627
Recruiting
Gulf War Illness is a condition that affects multiple major organ systems, resulting in a diverse array of symptoms that include debilitating fatigue, memory and cognition difficulties, headaches, sleep disturbances, gastrointestinal problems, skin rashes, and musculoskeletal/joint pain. This phase I single-site, open-label two-arm study will assess the safety and mechanistic efficacy of a sequential etanercept-mifepristone intervention for Gulf War Illness. The results of this phase I study wil... Read More
Gender:
Male
Ages:
Between 45 years and 70 years
Trial Updated:
01/29/2024
Locations: Miami VA Healthcare System, Miami, Florida
Conditions: Gulf War Illness
Register for Updates
A Study of LY3502970 in Participants With Impaired and Normal Liver Function
NCT05882032
Recruiting
The main purpose of this study is to measure how much of LY3502970 gets into the bloodstream and how long it takes the body to eliminate it in participants with mild, moderate and severe impaired liver function compared to participants with normal liver function. The safety and tolerability of LY3502970 will also be evaluated. The study may last up to 6 weeks for each participant including the screening period.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/29/2024
Locations: Clinical Pharmacology of Miami, Miami, Florida
Conditions: Healthy, Hepatic Insufficiency
Register for Updates
VLU Dressing Study
NCT03621592
Recruiting
The goal of the study is to investigate the effectiveness of Cutimed Sorbact (Study Device) in modifying bacterial load in venous leg ulcers (VLU).
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: University of Miami, Miami, Florida
Conditions: Venous Leg Ulcer
Register for Updates